1848P Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: Multicentre experience von Bas, O., Sert, L., Balcik, O.Y., Tokatli, M., Boyraz, N.E., Kavgaci, G., Sahin, T.K., Guven, D.C., Arik, Z., Isikdogan, A., Erman, M.

Volltext